Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome-Reference-Cited by-同舟云学术

Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome

Published:2022-04-01 Issue:4 Volume:7 Page:407
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Watanabe Hirotoshi¹,Morimoto Takeshi²,Natsuaki Masahiro³,Yamamoto Ko¹,Obayashi Yuki¹,Ogita Manabu⁴,Suwa Satoru⁴,Isawa Tsuyoshi⁵,Domei Takenori⁶,Yamaji Kyohei⁶,Tatsushima Shojiro⁷,Watanabe Hiroki⁷,Ohya Masanobu⁸,Tokuyama Hideo⁹,Tada Tomohisa¹⁰,Sakamoto Hiroki¹⁰,Mori Hiroyoshi¹¹,Suzuki Hiroshi¹¹,Nishikura Tenjin¹²,Wakabayashi Kohei¹²,Hibi Kiyoshi¹³,Abe Mitsuru¹⁴,Kawai Kazuya¹⁵,Nakao Koichi¹⁶,Ando Kenji⁶,Tanabe Kengo¹⁷,Ikari Yuji¹⁸,Morino Yoshihiro¹⁹,Kadota Kazushige⁸,Furukawa Yutaka²⁰,Nakagawa Yoshihisa²¹,Kimura Takeshi¹,Kozuma Ken²²,Hanaoka Keiichi²²,Tezuka Saori²²,Fujino Yumika²²,Kato Risa²²,Kitamura Masayo²²,Tsumori Miyuki²²,Hanazawa Miya²²,Yamauchi Misato²²,Yamazaki Itsuki²²,Hirokami Mitsugu²²,Makiguchi Nobuko²²,Nozaki Yoichi²²,Tomita Hirofumi²²,Yagi Masahiro²²,Komaru Tatsuya²²,Higuchi Motoaki²²,Isshiki Takaaki²²,Kodama Takahide²²,Tosaka Atsushi²²,Takamisawa Itaru²²,Tanaka Hiroyuki²²,Hata Yoshiki²²,Kato Ryuichi²²,Akashi Yoshihiro²²,Yumoto Kazuhiko²²,Tsukahara Kengo²²,Ako Junya²²,Onishi Yuko²²,Uzui Hiroyasu²²,Noda Toshiyuki²²,Morishima Itsuo²²,Yamada Minoru²²,Yoshida Ruka²²,Suzuki Susumu²²,Maeda Takuya²²,Tanigawa Takashi²²,Kaitani Kazuaki²²,Matsuoka Shunzo²²,Akao Masaharu²²,Yokomatsu Takafumi²²,Inoko Moriaki²²,Inada Tsukasa²²,Morita Takashi²²,Nakazawa Gaku²²,Ishihara Shozo²²,Kinoshita Makoto²²,Kusuyama Takanori²²,Togi Kiyonori²²,Tamura Toshihiro²²,Akasaka Takashi²²,Tabuchi Isao²²,Kihara Yasuki²²,Ueda Hironori²²,Katayama Yusuke²²,Wakeyama Takatoshi²²,Kaneko Takeo²²,Wakatsuki Tetsuzo²²,Kishi Koichi²²,Doi Masayuki²²,Okayama Hideki²²,Suematsu Nobuhiro²²,Inoue Shujiro²²,Natsuaki Masahiro²²,Tsujita Kenichi²²,Sakamoto Tomohiro²²,Kurokawa Hirofumi²²,Kashima Katsuro²²,Uehara Hiroki²²,

Affiliation:

1. Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan

2. Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan

3. Department of Cardiovascular Medicine, Saga University, Saga, Japan

4. Department of Cardiology, Juntendo University Shizuoka Hospital, Izunokuni, Japan

5. Department of Cardiology, Sendai Kousei Hospital, Sendai, Japan

6. Department of Cardiology, Kokura Memorial Hospital, Kitakyusyu, Japan

7. Department of Cardiology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan

8. Department of Cardiology, Kurashiki Central Hospital, Kurashiki, Japan

9. Department of Cardiology, Kawaguchi Cardiovascular and Respiratory Hospital, Kawaguchi, Japan

10. Department of Cardiology, Shizuoka General Hospital, Shizuoka, Japan

11. Showa University Fujigaoka Hospital, Yokohama, Japan

12. Showa University Koto Toyosu Hospital, Tokyo, Japan

13. Department of Cardiology, Yokohama City University Medical Center, Yokohama, Japan

14. Department of Cardiology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan

15. Department of Cardiology, Chikamori Hospital, Kochi, Japan

16. Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center, Kumamoto, Japan

17. Division of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan

18. Department of Cardiology, Tokai University Hospital, Isehara, Japan

19. Department of Cardiology, Iwate Medical University Hospital, Morioka, Japan

20. Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan

21. Department of Cardiovascular Medicine, Shiga University of Medical Science, Otsu, Japan

22. for the STOPDAPT-2 ACS Investigators

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Link

https://jamanetwork.com/journals/jamacardiology/articlepdf/2789701/jamacardiology_watanabe_2022_oi_210085_1648745334.74675.pdf

Reference34 articles.

1. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention, 2011 ACCF/AHA guideline for coronary artery bypass graft surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery.;Levine;Circulation,2016

2. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for Dual Antiplatelet Therapy in Coronary Artery Disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).;Valgimigli;Eur Heart J,2018

3. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.;Yusuf;N Engl J Med,2001

4. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.;Mehta;Lancet,2001

5. Defining high bleeding risk in patients undergoing percutaneous coronary intervention.;Urban;Circulation,2019

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Second-generation everolimus-eluting intracoronary stents: a comprehensive review of the clinical evidence;Future Cardiology;2024-01-31

2. Antiplatelet therapy in elderly patients with ACS: moving targets need more tailored treatments;Journal of Thrombosis and Thrombolysis;2024-01-28

3. Randomized evaluation of 5-month Ticagrelor monotherapy after 1-month dual-antiplatelet therapy in patients with acute coronary syndrome treated with drug-coated balloons: REC-CAGEFREE II trial rationale and design;BMC Cardiovascular Disorders;2024-01-20

4. De-escalation of dual antiplatelet therapy for patients with acute coronary syndrome after percutaneous coronary intervention: a systematic review and network meta-analysis;BMJ Evidence-Based Medicine;2024-01-19

5. Aspirin-free antiplatelet strategies after percutaneous coronary interventions;European Heart Journal;2024-01-18